Browse the corpus
Walk the Even Hospital Database by book and chapter — the raw source passages that ground Ask, DDx, and the rest.
1 passage
©2013 UpToDate ® Print Email 10 and 15-year likelihood of prostate cancer-specific survival after biochemical (PSA) recurrence following radical prostatectomy PSADT, months Riskestimate, percent (95 percent confidence interval) Recurrence>3 years after surgery Recurrence ≤3 years aftersurgery Gleason score <8 Gleason score ≥8 Gleason score <8 Gleason score ≥8 10-yearestimate ≥15.0 98 (96-100) 96 (93-98) 93 (80-98) 86 (61-96) 9.0-14.9 95 (75-99) 90 (58-98) 85 (49-97) 69 (30-92) 3.0-8.9 84 (62-94) 68 (37-89) 55 (25-82) 26 (7-62) <3.0 59 (29-83) 30 (10-63) 15 (3-53) 1 (<1-55) 15-yearestimate ≥15.0 94 (87-100) 87 (79-92) 81 (57-93) 62 (32-85) 9.0-14.9 86 (57-97) 72 (35-92) 59 (24-87) 31 (7-72) 3.0-8.9 59 (32-81) 30 (10-63) 16 (4-49) 1 (<1-2) <3.0 19 (5-51) 2 (<1-38) <1 (<1-26) <1 (<1-2) PSADT: prostate specific antigen doubling time. Data from Freedland, SJ, et al. JAMA 2005; 294:437.